Cargando…
Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women
Pathogenic variants in the BRCA1 and BRCA2 (BRCA1/2) genes are associated with elevated cancer risks in men and women. Due to a founder effect, Ashkenazi Jewish individuals are at higher risk for carrying three specific BRCA1/2 pathogenic variants. There have been recent calls for population screeni...
Autores principales: | Hardy, Melanie W., Peshkin, Beth N., Rose, Esther, Ladd, Mary Kathleen, Binion, Savannah, Tynan, Mara, McBride, Colleen M., Grinzaid, Karen A., Schwartz, Marc D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051789/ https://www.ncbi.nlm.nih.gov/pubmed/35486291 http://dx.doi.org/10.1007/s12687-022-00590-3 |
Ejemplares similares
-
Carrier screening in individuals of Ashkenazi Jewish descent
por: Gross, Susan J., et al.
Publicado: (2008) -
Beyond the “Jewish panel”: the importance of offering expanded carrier screening to the Ashkenazi Jewish population
por: Dolitsky, Shelley, et al.
Publicado: (2020) -
The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients
por: Chen-Shtoyerman, R, et al.
Publicado: (2001) -
Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
por: Tennen, Ruth I., et al.
Publicado: (2020) -
A collaborative genetic carrier screening model for the British Ashkenazi Jewish community
por: Ziff, Monica, et al.
Publicado: (2021)